Mesenchymal stem cells are highly resistant to sulfur mustard

Chemico-Biological Interactions

Volumn 206, Issue 3, 2013, Pages 505-511

  Schmidt, Annette ^a,b   Scherer, Michael ^c   Thiermann, Horst ^a   Steinritz, Dirk ^a,d  

^a BUNDESWEHR INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (Germany)

^b GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^c Amper Clinics   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Differentiation; Mesenchymal stem cells; Migration; Resistance; Sulfur mustard

Indexed keywords

MUSTARD GAS;

ADIPOGENESIS; ADULT; AGED; ARTICLE; BONE DEVELOPMENT; CELL ASSAY; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR STRESS RESPONSE; CHONDROGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMUR HEAD; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYMAL STEM CELL; MIDDLE AGED; NERVE CELL DIFFERENTIATION; PHYSICAL RESISTANCE; SENSITIVITY ANALYSIS; SKIN INJURY; TOXICITY TESTING; VERY ELDERLY; WOUND HEALING; WOUND HEALING IMPAIRMENT;

DIFFERENTIATION; MESENCHYMAL STEM CELLS; MIGRATION; RESISTANCE; SULFUR MUSTARD;

ADIPOGENESIS; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; CHEMICAL WARFARE AGENTS; CHONDROGENESIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MESENCHYMAL STROMAL CELLS; MUSTARD GAS; NEUROGENESIS; NEURONS; OSTEOGENESIS; SKIN; WOUND HEALING;

EID: 84890116801     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2013.07.013     Document Type: Article

References (31)

1. S.N. Emadi, F. Babamahmoodi, Z. Poursaleh, S.S. Sayad-Noori, M.R. Soroush, A.R. Maleki, M. Izadi, M.R. Khodaei-Ardakan, and S.E. Emadi Sezary syndrome, Kaposi sarcoma and generalized dermatophytosis 15 years after sulfur mustard gas exposure J. Dermatol. Case Rep. 6 2012 86 89
2. S.N. Emadi, F. Moeineddin, and M.R. Sorush Urinary and cutaneous complications of sulphur mustard poisoning preceding pulmonary and ocular involvement: an unusual sequence of symptoms Clin. Exp. Dermatol. 34 2009 e7 e10
3. S.N. Emadi, M. Mortazavi, and H. Mortazavi Late cutaneous manifestations 14-20 years after wartime exposure to sulfur mustard gas: a long-term investigation Arch. Dermatol. 144 2008 1059 1061
4. J.S. Graham, R.P. Chilcott, P. Rice, S.M. Milner, C.G. Hurst, and B.I. Maliner Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies J. Burns Wounds 4 2005 e1
5. Z.M. Hassan, and M. Ebtekar Immunological consequence of sulfur mustard exposure Immunol. Lett. 83 2002 151 152 (Pubitemid 34722346)
6. T. Schinkothe, W. Bloch, and A. Schmidt In vitro secreting profile of human mesenchymal stem cells Stem Cells Dev. 17 2008 199 206
7. C. Fathke, L. Wilson, J. Hutter, V. Kapoor, A. Smith, A. Hocking, and F. Isik Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair Stem Cells 22 2004 812 822 (Pubitemid 39166938)
8. A.J. Singer, and R.A. Clark Cutaneous wound healing N. Engl. J. Med. 341 1999 738 746 (Pubitemid 29407375)
9. L. Rodriguez-Menocal, M. Salgado, D. Ford, and E. Van Badiavas Stimulation of skin and wound fibroblast migration by mesenchymal stem cells derived from normal donors and chronic wound patients Stem Cells Transl. Med. 1 2012 221 229
10. A. Schmidt, D. Ladage, T. Schinkothe, U. Klausmann, C. Ulrichs, F.J. Klinz, K. Brixius, S. Arnhold, B. Desai, U. Mehlhorn, R.H. Schwinger, P. Staib, K. Addicks, and W. Bloch Basic fibroblast growth factor controls migration in human mesenchymal stem cells Stem cells 24 2006 1750 1758 (Pubitemid 44474188)
11. V. Paromov, S. Kumari, M. Brannon, N.S. Kanaparthy, H. Yang, M.G. Smith, and W.L. Stone Protective effect of liposome-encapsulated glutathione in a human epidermal model exposed to a mustard gas analog J. Toxicol. 2011 2011 109516
12. V. Paromov, M. Brannon, S. Kumari, M. Samala, M. Qui, M. Smith, and W.L. Stone Sodium pyruvate modulates cell death pathways in HaCaT keratinocytes exposed to half-mustard gas Int. J. Toxicol. 30 2011 197 206
13. N. Tewari-Singh, C. Agarwal, J. Huang, B.J. Day, C.W. White, and R. Agarwal Efficacy of glutathione in ameliorating sulfur mustard analog-induced toxicity in cultured skin epidermal cells and in SKH-1 mouse skin in vivo J. Pharmacol. Exp. Ther. 336 2011 450 459
14. N. Tewari-Singh, M. Gu, C. Agarwal, C.W. White, and R. Agarwal Biological and molecular mechanisms of sulfur mustard analogue-induced toxicity in JB6 and HaCaT cells: possible role of ataxia telangiectasia-mutated/ataxia telangiectasia-Rad3-related cell cycle checkpoint pathway Chem. Res. Toxicol. 23 2010 1034 1044
15. A. Heinrich, F. Balszuweit, H. Thiermann, and K. Kehe Rapid simultaneous determination of apoptosis, necrosis, and viability in sulfur mustard exposed HaCaT cell cultures Toxicol. Lett. 191 2009 260 267
16. D. Steinritz, A. Elischer, F. Balszuweit, S. Gonder, A. Heinrich, W. Bloch, H. Thiermann, and K. Kehe Sulphur mustard induces time- and concentration-dependent regulation of NO-synthesizing enzymes Toxicol. Lett. 188 2009 263 269
17. C. Ries, T. Popp, V. Egea, K. Kehe, and M. Jochum Matrix metalloproteinase-9 expression and release from skin fibroblasts interacting with keratinocytes: Upregulation in response to sulphur mustard Toxicology 263 2009 26 31
18. C.D. Lindsay, E. Gentilhomme, and J.D. Mathieu The use of doxycycline as a protectant against sulphur mustard in HaCaT cells J. Appl. Toxicol. 28 2008 665 673 (Pubitemid 352009757)
19. K. Kehe, K. Raithel, H. Kreppel, M. Jochum, F. Worek, and H. Thiermann Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells Arch. Toxicol. 82 2008 461 470
20. R. Simpson, and C.D. Lindsay Effect of sulphur mustard on human skin cell lines with differential agent sensitivity J. Appl. Toxicol. 25 2005 115 128 (Pubitemid 40488488)
21. K. Balakrishnan, J.A. Burger, M.P. Quiroga, M. Henneberg, M.L. Ayres, W.G. Wierda, and V. Gandhi Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells Blood 116 2010 1083 1091
22. F. Vianello, F. Villanova, V. Tisato, S. Lymperi, K.K. Ho, A.R. Gomes, D. Marin, D. Bonnet, J. Apperley, E.W. Lam, and F. Dazzi Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis Haematologica 95 2010 1081 1089
23. S. Iwamoto, K. Mihara, J.R. Downing, C.H. Pui, and D. Campana Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase J. Clin. Invest. 117 2007 1049 1057 (Pubitemid 46556761)
24. A. Scherzed, S. Hackenberg, K. Froelich, M. Kessler, C. Koehler, R. Hagen, A. Radeloff, G. Friehs, and N. Kleinsasser BMSC enhance the survival of paclitaxel treated squamous cell carcinoma cells in vitro Cancer Biol. Ther. 11 2011 349 357
25. R. Lis, C. Touboul, P. Mirshahi, F. Ali, S. Mathew, D.J. Nolan, M. Maleki, S.A. Abdalla, C.M. Raynaud, D. Querleu, E. Al-Azwani, J. Malek, M. Mirshahi, and A. Rafii Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12 Int. J. Cancer 128 2011 715 725
26. M.B. Meads, L.A. Hazlehurst, and W.S. Dalton The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance Clin. Cancer Res. 14 2008 2519 2526
27. J.M. Houthuijzen, L.G. Daenen, J.M. Roodhart, and E.E. Voest The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression Br. J. Cancer 106 2012 1901 1906
28. K. Kemp, R. Morse, K. Sanders, J. Hows, and C. Donaldson Alkylating chemotherapeutic agents cyclophosphamide and melphalan cause functional injury to human bone marrow-derived mesenchymal stem cells Ann. Hematol. 90 2011 777 789
29. S. Cho, E. Gorjup, and H. Thielecke Chip-based time-continuous monitoring of toxic effects on stem cell differentiation Ann. Anat. 191 2009 145 152
30. M.J. Hoogduijn, Z. Rakonczay, and P.G. Genever The effects of anticholinergic insecticides on human mesenchymal stem cells Toxicol. Sci. 94 2006 342 350 (Pubitemid 44817150)
31. S. Wislet-Gendebien, E. Laudet, V. Neirinckx, and B. Rogister Adult bone marrow: which stem cells for cellular therapy protocols in neurodegenerative disorders? J. Biomed. Biotechnol. 2012 2012 601560